Clinical Trials Directory

Trials / Completed

CompletedNCT01918891

Center for Stroke Disparities Solution - Community Transitions Intervention

Center for Stroke Disparities Solution (CSDS) Project II: Community Transitions Intervention (CTI)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
495 (actual)
Sponsor
Visiting Nurse Service of New York · Academic / Other
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

The Stroke CTI study is a 3 arm randomized, controlled trial designed to assess the effectiveness of a nurse practitioner (NP) only and a NP and health coach (HC) community transitions intervention (CTI) in reducing secondary stroke risk by helping patients lower their systolic blood pressure.

Detailed description

Targeted study participants are Black and Hispanic patients with a history of stroke and a current systolic blood pressure (BP) above JNC7 recommended range (\>=140 mmHg) who recently entered home care service. The NP only program will provide a 30 day intervention while the NP/HC team will provide 3 months of support via in-home and telephone encounters for patients randomized to one of these groups. In the first 30 days post-enrollment the NP will focus on medical case management and coordination with primary care providers and specialists, provide self-management coaching, and intervene if gaps in care are identified - all with a focus on BP reduction and preparing the patient for ongoing BP maintenance. As applicable, the HC will pick up the case after 30 days and follow up with the plan of care jointly established by the patient, NP and HC. The focus will be on ongoing self-management coaching, providing preparation support for physician visits, and linking patient to additional community resources, as needed.

Conditions

Interventions

TypeNameDescription
BEHAVIORALNurse Practitioner Only
BEHAVIORALNurse Practitioner + Health Coach

Timeline

Start date
2012-09-01
Primary completion
2018-06-01
Completion
2018-06-01
First posted
2013-08-08
Last updated
2019-10-01

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01918891. Inclusion in this directory is not an endorsement.